Literature DB >> 19427103

Spatial distribution of ultrasound targeted microbubble destruction increases cardiac transgene expression but not capillary permeability.

Nicolas A Geis1, Christian R Mayer, Richard D Kroll, Stefan E Hardt, Hugo A Katus, Raffi Bekeredjian.   

Abstract

Ultrasound targeted microbubble destruction (UTMD) has evolved as a promising tool for organ specific gene and drug delivery. Using DNA-loaded microbubbles, cardiac transfection has been shown to be feasible. However, two-dimensional properties of the ultrasound beam limit cardiac transgene expression to the focal zone, thus, reducing its potential therapeutic effect. The aim of this study was to test if spatial distribution of ultrasound targeted microbubble destruction in the heart could lead to augmented transgene expression or increased capillary permeability. Lipid microbubbles containing plasmids with a luciferase transgene were used to target rat hearts. The diagnostic ultrasound probe was fixed in a mid-short axis view with a gel stand-off between the chest and probe. Ultrasound (1.3 MHz) with a mechanical index of 1.6 was intermittently applied to rats during microbubble infusion. Rats were randomized to either stay in that position or move horizontally in a cranio-caudal direction (3 mm sweep) relative to the ultrasound probe during UTMD. After 4 days, organs were harvested and analyzed for reporter gene expression. Another group of rats received Evans Blue, followed by UTMD with unloaded microbubbles. Again, rats were randomized into a static or moving group. Hearts were harvested to evaluate extravasation of Evans Blue. Moving rats in a cranio-caudal direction significantly increased transgene expression by 19-fold in the anterior heart, by sixfold in the posterior heart and by 32-fold in the apex. Interestingly, Evans Blue extravasation was not augmented in the moving group. Spatial distribution of UTMD may increase transgene expression due to sonication of larger areas in the heart. In contrast, capillary permeability does not increase, indicating less capillary damage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19427103     DOI: 10.1016/j.ultrasmedbio.2009.01.008

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  7 in total

1.  Ultrasound-triggered microbubble destruction in combination with cationic lipid microbubbles enhances gene delivery.

Authors:  Li Zhang; Yingying Liu; Guangya Xiang; Qing Lv; Gui Huang; Yali Yang; Yanrong Zhang; Yue Song; Huan Zhou; Mingxing Xie
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-02-19

2.  Proliferation inhibition and apoptosis enhancement of human cervical cancer cells by ultrasound-targeted microbubble destruction delivered double suicide genes.

Authors:  Yi Hao; Li Guo; Abulizi Abudula; Wuliyati Saidoula; Xia Guo
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 3.  Ultrasonic technologies in imaging and drug delivery.

Authors:  Yi-Ju Ho; Chih-Chung Huang; Ching-Hsiang Fan; Hao-Li Liu; Chih-Kuang Yeh
Journal:  Cell Mol Life Sci       Date:  2021-07-23       Impact factor: 9.261

Review 4.  Nucleic acid delivery with microbubbles and ultrasound.

Authors:  Joshua J Rychak; Alexander L Klibanov
Journal:  Adv Drug Deliv Rev       Date:  2014-01-31       Impact factor: 15.470

5.  Synergistic anti-tumor effect of paclitaxel and miR-34a combined with ultrasound microbubbles on cervical cancer in vivo and in vitro.

Authors:  J Yu; Y Zhao; C Liu; B Hu; M Zhao; Y Ma; J Jiang
Journal:  Clin Transl Oncol       Date:  2019-05-15       Impact factor: 3.405

6.  Focused ultrasound and microbubbles for enhanced extravasation.

Authors:  M R Böhmer; C H T Chlon; B I Raju; C T Chin; T Shevchenko; A L Klibanov
Journal:  J Control Release       Date:  2010-06-26       Impact factor: 9.776

7.  Enhanced ultrasound imaging and anti-tumor in vivo properties of Span-polyethylene glycol with folic acid-carbon nanotube-paclitaxel multifunctional microbubbles.

Authors:  Jie Zhang; Limei Song; Shujing Zhou; Ming Hu; Yufeng Jiao; Yang Teng; Ying Wang; Xiangyu Zhang
Journal:  RSC Adv       Date:  2019-10-31       Impact factor: 3.361

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.